Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" provides data on the Systemic Sclerosis (Scleroderma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systemic Sclerosis (Scleroderma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systemic Sclerosis (Scleroderma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Summary
GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2011" provides data on the Systemic Sclerosis (Scleroderma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systemic Sclerosis (Scleroderma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systemic Sclerosis (Scleroderma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents
Table of ContentsList of Tables
List of Figures
Introduction
Systemic Sclerosis (Scleroderma)
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Systemic Sclerosis (Scleroderma)
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Actelion Ltd
Clinical Trial Overview of Actelion Ltd
United Therapeutics Corporation
Clinical Trial Overview of United Therapeutics Corporation
MediQuest Therapeutics, Inc.
Clinical Trial Overview of MediQuest Therapeutics, Inc.
Benesis Corporation
Clinical Trial Overview of Benesis Corporation
MedImmune, LLC
Clinical Trial Overview of MedImmune, LLC
Roche Nederland B.V.
Clinical Trial Overview of Roche Nederland B.V.
Daval International Ltd.
Clinical Trial Overview of Daval International Ltd.
Amira Pharmaceuticals, Inc.
Clinical Trial Overview of Amira Pharmaceuticals, Inc.
Italfarmaco S.p.A.
Clinical Trial Overview of Italfarmaco S.p.A.
Active Biotech AB
Clinical Trial Overview of Active Biotech AB
Novartis AG
Clinical Trial Overview of Novartis AG
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Allergan, Inc.
Clinical Trial Overview of Allergan, Inc.
Genzyme Corporation
Clinical Trial Overview of Genzyme Corporation
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
The National Institute of Allergy and Infectious Diseases
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
Rouen University Hospital
Clinical Trial Overview of Rouen University Hospital
University of Michigan
Clinical Trial Overview of University of Michigan
Johns Hopkins University
Clinical Trial Overview of Johns Hopkins University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Stanford University
Clinical Trial Overview of Stanford University
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Hospital for Special Surgery
Clinical Trial Overview of Hospital for Special Surgery
University of Medicine and Dentistry New Jersey
Clinical Trial Overview of University of Medicine and Dentistry New Jersey
Duke University
Clinical Trial Overview of Duke University
Boston University
Clinical Trial Overview of Boston University
Federal University of Sao Paulo
Clinical Trial Overview of Federal University of Sao Paulo
Charite University
Clinical Trial Overview of Charite University
Georgetown University
Clinical Trial Overview of Georgetown University
Northwestern University
Clinical Trial Overview of Northwestern University
University of Dundee
Clinical Trial Overview of University of Dundee
Ghent University Hospital
Clinical Trial Overview of Ghent University Hospital
Universita' Politecnica delle Marche
Clinical Trial Overview of Universita' Politecnica delle Marche
Alexandria University
Clinical Trial Overview of Alexandria University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MediQuest Therapeutics, Inc., 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Benesis Corporation, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Nederland B.V., 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daval International Ltd., 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amira Pharmaceuticals, Inc., 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Italfarmaco S.p.A., 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Active Biotech AB, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital for Special Surgery, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita' Politecnica delle Marche, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexandria University, 2012*
LIST OF FIGURES
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top